Table 2 |
||||||||||
|
Frequency of association between subtypes of lobular neoplasia and columnar cell lesions (CCL) |
||||||||||
|
CCL |
ALH |
DIALH |
LCIS |
LCIS pleo |
Total |
|||||
|
n |
% |
n |
% |
n |
% |
n |
% |
n |
% |
|
|
|
||||||||||
|
CCC |
14 |
22.6 |
13 |
21.0 |
15 |
24.2 |
0 |
0 |
42 |
67.7 |
|
CCH |
4 |
6.5 |
3 |
4.8 |
2 |
3.2 |
0 |
0 |
9 |
14.5 |
|
CCC with atypia |
1 |
1.6 |
3 |
4.8 |
4 |
6.5 |
1 |
1.6 |
9 |
14.5 |
|
CCH with atypia |
0 |
0 |
0 |
0.0 |
1 |
1.6 |
1 |
1.6 |
2 |
3.2 |
|
Total |
19 |
30.6 |
19 |
30.6 |
22 |
35.5 |
2 |
3.2 |
62 |
100.0 |
|
|
||||||||||
|
ALH = atypical lobular hyperplasia; DIALH = ductal involvement by cells of atypical lobular hyperplasia; LCIS = lobular carcinoma in situ; LCIS pleo = LCIS pleomorphic; CCC = columnar cell change; CCH = columnar cell hyperplasia; CCC with atypia = columnar cell change with atypia; CCH with atypia = columnar cell hyperplasia with atypia; n = number of cases. χ2 test for trend: p = 0.03. |
||||||||||
|
Gomes et al. Diagnostic Pathology 2011 6:74 doi:10.1186/1746-1596-6-74 |
||||||||||
